The global nasal drug delivery technology market size was valued at USD 78.64 billion in 2024 and is expected to reach USD 135.12 billion by 2032, at a CAGR of 7.00% during the forecast period

This growth is driven by factors such as the increasing prevalence of chronic respiratory diseases, the rising geriatric population, advancements in drug formulation technologies, growing demand for non-invasive drug delivery methods, and increased patient preference for self-administration